skip to Main Content

TAG EU and UK TB Research and Development Advocacy Consultant

TAG is seeking a consultant to advance strategic policy-advocacy and resource mobilization efforts for TB R&D in the context of EU and UK global development cooperation. The consultant will be responsible for engaging policymakers, investigating legislative opportunities, and executing advocacy strategies in collaboration with TAG to increase TB R&D resources in the region.
Read more

TAG Comments on NIST’s Proposed Rulemaking Changes

TAG submitted comments in response to the National Institute of Standards and Technology's (NIST) proposed change to rulemaking, strongly opposing amendments to remove crucial public health safeguards from the Bayh-Dole Act. March-in rights and other provisions to hold manufacturers accountable when federally funded inventions are exorbitantly priced and are critically important to public health and the right to science.
Read more

Civil Society Letter to Donors, Countries, and Health Actors to Improve Access to GeneXpert and Other Diagnostics

TAG led an open letter appealing to donors, countries, and health actors to improve access to GeneXpert and other diagnostics for COVID-19, TB, HIV, HBV, HCV, and other diseases by applying collective leverage in negotiations with Cepheid for lower prices and sufficient volumes; establishing cost-of-goods-sold (COGS)-plus and volume-based pricing for diagnostics as a global norm; and increasing investments in alternative rapid molecular tests to promote competition and improve access.
Read more
Back To Top